-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
-
Summary
-
Amneal Pharmaceuticals, Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from 2016 to 2023.
- Amneal Pharmaceuticals, Inc. Income Tax Expense (Benefit) for the quarter ending June 30, 2024 was $3.62M.
- Amneal Pharmaceuticals, Inc. Income Tax Expense (Benefit) for the twelve months ending June 30, 2024 was $17.6M, a 414% increase year-over-year.
- Amneal Pharmaceuticals, Inc. annual Income Tax Expense (Benefit) for 2023 was $8.45M, a 26.9% increase from 2022.
- Amneal Pharmaceuticals, Inc. annual Income Tax Expense (Benefit) for 2022 was $6.66M, a 40.5% decline from 2021.
- Amneal Pharmaceuticals, Inc. annual Income Tax Expense (Benefit) for 2021 was $11.2M.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Annual (USD)
Income Tax Expense (Benefit), YoY Annual Growth (%)